Article Figures & Data
Figures
- Figure 1.
Process for identifying trans patients eligible for cervical, breast, or colorectal cancer screening
EMR—electronic medical record, MRP—most responsible provider (physician or nurse practitioner).
Tables
- Table 1.
Definitions for identifying patients eligible and up-to-date for cancer screening based on trans care guidelines11 and provincial cancer screening guidelines12
TYPE OF CANCER SCREENING ELIGIBLE PATIENTS DEFINITION OF UP-TO-DATE FOR SCREENING EXCLUSIONS Cervical Assigned female at birth, aged 21 to 69 y Received a Papanicolaou test in the previous 36 mo Previous total hysterectomy or cervical cancer Breast Assigned female at birth, aged 50 to 74 y
Assigned male at birth, aged 50 to 74 y taking estrogen for > 5 yReceived a mammogram in the previous 24 mo Previous mastectomy or breast cancer Colorectal Adults aged 50 to 74 y Received either FOBT in the previous 24 mo or flexible sigmoidoscopy in the previous 5 y or a colonoscopy in the previous 10 y Previous colon cancer or colectomy FOBT—fecal occult blood testing.
CHARACTERISTICS TRANS PATIENTS (N = 120), N (%) CIS PATIENTS (N = 20 514), N (%) P VALUE* Age, y < .001 • 21–29 38 (32) 1931 (9) • 30–39 33 (28) 4083 (20) • 40–49 11 (9) 3215 (16) • 50–59 23 (19) 5892 (29) • 60–74 15 (13) 5393 (26) Assigned sex at birth .361 • Female 91 (76) 14 787 (72) • Male 29 (24) 5727 (28) Neighbourhood income quintile† .009 • 1 (lowest) 41 (36) 5213 (27) • 2 25 (22) 3146 (16) • 3 16 (14) 3254 (17) • 4 17 (15) 3253 (17) • 5 (highest) 14 (12) 4706 (24) No. of primary care visits in the previous 1 y < .001 • 0 23 (19) 4741 (23) • 1 14 (12) 3888 (19) • 2–3 23 (19) 5948 (29) • 4–10 49 (41) 5217 (25) • ≥ 11 11 (9) 720 (4) TYPE OF CANCER SCREENING TRANS PATIENTS (N = 120) CIS PATIENTS (N = 20 514) P VALUE* NO. ELIGIBLE FOR SCREENING TEST SCREENED, % NO. ELIGIBLE FOR SCREENING TEST SCREENED, % Cervical 86 56 13 683 72 .001 Breast 30 33 5265 65 < .001 Colorectal 38 55 11 247 70 .046 ↵*
2 statistic comparing percentage screened among cisgender versus transgender patients.
- Table 4.
Unadjusted and adjusted ORs comparing likelihood of trans individuals being screened for cancer compared with cis individuals
TYPE OF CANCER SCREENING UNADJUSTED OR (95% CI) ADJUSTED OR* (95% CI) Cervical 0.46 (0.30 to 0.72) 0.39 (0.25 to 0.62) Breast 0.28 (0.13 to 0.60) 0.27 (0.12 to 0.59) Colorectal 0.51 (0.27 to 0.99) 0.50 (0.26 to 0.99) OR—odds ratio.
↵* Adjusted for age, neighbourhood income quintile, and number of visits.
CFPlus Additional Information
